Galectin Therapeutics (GALT) Files 2M Share Stock Shelf for Selling Shareholders

August 16, 2016 8:54 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Galectin Therapeutics (Nasdaq: GALT) filed a registration with the U.S. SEC to sell up to 2 million shares of common stock on behalf of selling shareholders.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Add Your Comment